Abstract

Neuronal nicotinic acetylcholine receptors (nAChRs) are prototypical cation-selective, ligand-gated ion channels that mediate fast neurotransmission in the central and peripheral nervous systems. nAChRs are involved in a range of physiological and pathological functions and hence are important therapeutic targets. Their subunit homology and diverse pentameric assembly contribute to their challenging pharmacology and limit their drug development potential. Toxins produced by an extensive range of algae, plants and animals target nAChRs, with many proving pivotal in elucidating receptor pharmacology and biochemistry, as well as providing templates for structure-based drug design. The crystal structures of these toxins with diverse chemical profiles in complex with acetylcholine binding protein (AChBP), a soluble homolog of the extracellular ligand-binding domain of the nAChRs and more recently the extracellular domain of human α9 nAChRs, have been reported. These studies have shed light on the diverse molecular mechanisms of ligand-binding at neuronal nAChR subtypes and uncovered critical insights useful for rational drug design. This review provides a comprehensive overview and perspectives obtained from structure and function studies of diverse plant and animal toxins and their associated inhibitory mechanisms at neuronal nAChRs.

Highlights

  • Structure of Neuronal Nicotinic Acetylcholine Receptors nAChRs are formed by the assembly of five transmembrane subunits

  • This review provides a comprehensive overview and perspectives obtained from structure and function studies of diverse plant and animal toxins and their associated inhibitory mechanisms at neuronal nAChRs

  • Challenges for researchers and clinicians to elucidate the role of particular nAChR subtypes arise from the vast diversity of neuronal nAChRs subtypes expressed in the central nervous system (CNS) and peripheral nervous system (PNS)

Read more

Summary

Introduction

Structure of Neuronal Nicotinic Acetylcholine Receptors (nAChRs) nAChRs are formed by the assembly of five transmembrane subunits. The ligand binding pocket (LBP) for agonists or antagonist in nAChRs is at the interface between two neighboring subunits with one subunit being the principal face and the other being the complementary face (Figure 1B). The binding of ligand stimulates different functional states of nAChRs via the conformational changes induced by the relative movement of the five subunits to each other (Liu et al, 2008). The structural characters of the LBP and the specific amino acid interactions between ligands and this site determine the conformational transitions that lie behind the pharmacological properties of a specific neuronal nAChR subtype (Dani and Bertrand, 2007). Different pharmacological and biophysical properties are displayed by a diverse range of neuronal nAChR subtypes underpinned by the different subunit combinations.

Objectives
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call